This project is based on a recent observation that osteoblasts are a regulatory component of thehematopoietic stem cell niche and can be targeted as a means to increase stem cell numbers. Activation ofthe parathyroid hormone (PTH)/parathyroid related hormone receptor (PPR) resulted in Notch pathwayactivation and thereby expansion of hematopoietic stem cells in a mouse model. This was accompanied by amarked improvement in animal survival following bone marrow transplantation with limiting numbers ofhematopoietic stem cells. This project will assess the potential for extending this model to a clinical contextby pursuing the following specific aims:
Aim 1 : Define whether stimulation of the stem cell niche with PTH can result in improved donor stem cellharvests.
Aim 2 : Determine if manipulation of the graft or niche can affect the kinetics of immune recovery.
Aim 3 : Determine if ex vivo manipulation of the graft and the niche can synergistically increase stem cellengraftment efficiency.Accomplishment of these aims depends upon the clinical and large animal components of this ProgramProject and would not be achievable without the PO1 mechanism. Successful completion of this project willprovide critical information about the value of using PTH specifically and targeting the stem cell niche moregenerally in stem cell based therapies for human disease.
Showing the most recent 10 out of 36 publications